Developer docs
API playgroundTry for free, no card

Search company profiles

Rock Labs

Full company profile

uuid0021hip

Namestring
Rock Labs
Legal namestring
Rock Labs Ltd
Websiteurl
rocklabs.co
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Rock Labs is a UK-based, privately held health technology company developing point-of-care cortisol monitoring technology for endocrine health management, with particular focus on adrenal insufficiency. The company serves two primary customer personas: patients and carers managing hormonal conditions who lack practical day-to-day monitoring tools, and clinicians supporting those patients who need longitudinal visibility beyond clinic visits. Its business is presently structured as pre-revenue clinical development rather than commercial sales, with the company explicitly stating its technology is in clinical trials and not available outside regulated pathways.

The company's product portfolio centers on two offerings. The core Cortisol Monitoring Technology is a point-of-care sensing programme combining proprietary sensing hardware, algorithms, secure data handling, and analysis software designed to support both patients and clinicians within regulatory pathways. A complementary Symptom-Tracker mobile application has been developed to help parents manage childhood adrenal insufficiency at home via patient-reported data. Technical differentiation is grounded in domain specialisation in endocrine health rather than general-purpose biosensing, with hardware, algorithms, and user experience refined in collaboration with NHS clinical teams and patients.

Rock Labs operates on a planned subscription/recurring revenue model to be activated post-approval, with anticipated distribution routed through health systems, payers, and pharmaceutical partners rather than direct consumer sales. Its commercial pipeline is anchored by three core strategic partners: the NHS, Royal Manchester Children's Hospital (clinical co-development), and The Pituitary Foundation (patient advocacy and lived-experience input). Company research has been disseminated through poster abstracts at the British Society for Paediatric Endocrinology and Diabetes (BSPED) annual meetings in 2024 and 2025, published in Endocrine Abstracts. The company is small (1-10 employees), bootstrapped or grant-funded to date, and led by Founder & CEO Ben Marinic with an advisory bench including Prof. Indi Banerjee (paediatric endocrinology) and Bev Hurley CBE (commercialisation).

Short descriptiontext

Rock Labs is a UK-based pre-revenue health technology company developing point-of-care cortisol monitoring sensing hardware and a symptom-tracking mobile app for patients with hormonal conditions, currently in early clinical trials with the NHS.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cortisol monitoring, endocrine health platform, digital health sensing, clinical decision support, symptom tracking app
Industry4 codes
PRIMARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLACAOAL
Decentralized/Hybrid Trial Enablement (DCT) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
NAICS code2 codes
  • Medical and Diagnostic Laboratories62151
  • Medical Laboratories621511
SIC code3 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Prepackaged Software7372
Product category
Digital Health — Endocrine Health Monitoring
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pre-Revenue / Development Stage
TypeSubscription Recurring
Description

Rock Labs is in clinical trials stage with its technology. The company works with health systems, payers, and pharmaceutical partners who help make tools available to patients when evidence and approvals support that. No commercial revenue has been generated as the technology is not yet a finished product.

rocklabs.co
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Others
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Core offering1 text field

Rock Labs develops an integrated point-of-care cortisol monitoring platform that combines proprietary sensing hardware, secure data handling, and software with AI/ML analytics to support patients and clinicians in managing cortisol-related hormonal conditions such as adrenal insufficiency. A complementary symptom-tracker mobile application supports home management, particularly for paediatric adrenal insufficiency. The technology is currently in early clinical trials in collaboration with the NHS and is not yet a commercially available finished product.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Rock Labs is developing an integrated endocrine health platform focused on cortisol monitoring. The core offering consists of a point-of-care cortisol monitoring technology (currently in early clinical trials) that combines sensing hardware, secure data handling, and analysis software to support both patients and clinicians. A complementary symptom-tracker mobile application has been developed for home management of childhood adrenal insufficiency. The platform is designed to provide precise, longitudinal insight into cortisol-related health, with an emphasis on real-life usability rather than clinical settings alone.

Product and service2 records
1Cortisol Monitoring Technology
CategoryCore platform — digital health / medical device software
Description

An integrated point-of-care cortisol monitoring platform combining proprietary sensing hardware, secure data handling, and analysis software (including AI/ML) to provide longitudinal insight into cortisol-related health. Designed to support both patients living with hormonal conditions such as adrenal insufficiency and the clinicians who care for them. Currently in early clinical trials and not yet a finished commercial product.

2Symptom-Tracker App
CategoryMobile application — patient-facing software
Description

A mobile application designed to help parents manage childhood adrenal insufficiency at home by enabling symptom tracking and supporting optimisation of treatment plans through patient-reported data. Developed in collaboration with NHS clinical teams and The Pituitary Foundation with lived-experience input from families.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1NHS
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NHS partnership for developing and validating endocrine health monitoring technologies. The collaboration supports making Rock Labs tools available to patients through health system pathways when evidence and approvals support that.

rocklabs.co
2Royal Manchester Children's Hospital
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical collaboration with NHS clinical teams at Royal Manchester Children's Hospital for developing monitoring tools, particularly for adrenal insufficiency in pediatric patients. Team members have co-authored research with hospital staff.

rocklabs.co
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Patient advocacy partnership with The Pituitary Foundation including lived-experience input into product development. Collaboration ensures tools are grounded in real patient and carer needs.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Leading continuous glucose monitoring company with established hardware, software, and clinical evidence infrastructure. Comparable business model (continuous biochemical sensing + app + clinical decision support) and a benchmark for what successful endocrine monitoring scale looks like.

2Function Health
TypeEmerging player
Description

Comprehensive at-home biomarker and lab testing platform with a software layer for longitudinal tracking and clinical decision support. Comparable in combining diagnostic testing, consumer health focus, and longitudinal data platform, though broader than endocrine.

TypeEmerging player
Description

UK-headquartered digital health platform combining remote patient monitoring, decentralized clinical trials, and AI-driven decision support. Comparable in combining RPM software, clinical partnerships, and pharma/health-system GTM, but operating at much broader scale.

TypeDirect peer
Description

UK-based at-home blood testing service delivering biomarker results to consumers with clinician follow-up. Comparable to Rock Labs as a UK digital health company translating lab diagnostics into consumer/patient-friendly monitoring, though Thriva is further along commercially and not focused on cortisol.

TypeBroad incumbent
Description

Global diagnostics incumbent with established cortisol immunoassays and immunoassay platforms used in clinical labs. Comparable on the diagnostic substance/testing side; an incumbent Rock Labs must differentiate against on performance, accessibility, and patient experience.

TypeDirect peer
Description

UK-based at-home blood testing platform offering a wide range of hormone and endocrine panels, including cortisol. Similar at-home diagnostic model and UK regulatory pathway, with overlap in target endocrinology use cases.

TypeDirect peer
Description

US consumer metabolic monitoring company using continuous glucose sensing plus software to give users real-time insight and clinical decision support. Closely comparable model: sensing hardware + software + AI for day-to-day metabolic/hormonal condition management.

8Biofourmis
TypeEmerging player
Description

AI-driven remote patient monitoring and decentralized clinical trial platform focused on chronic conditions. Comparable technology stack (sensors + software + AI for clinical decision support) and enterprise health-system go-to-market motion.

9Spren
TypeEmerging player
Description

Digital health startup using sensors and software to track hormonal biomarkers (cortisol) via wearable signals. Closely comparable in combining novel sensing with a software/AI layer to surface cortisol insight for consumers and clinicians.

10Abbott (Diagnostics & Diabetes Care)
TypeBroad incumbent
Description

Global diagnostics and medical device incumbent operating FreeStyle Libre CGM and a broad immunoassay portfolio that includes cortisol testing. Comparable on the cortisol diagnostic side and a likely competitive threat via scale, distribution, and clinical evidence resources.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rock Labs

Digital Health — Endocrine Health Monitoringrocklabs.co

Rock Labs is a UK-based pre-revenue health technology company developing point-of-care cortisol monitoring sensing hardware and a symptom-tracking mobile app for patients with hormonal conditions, currently in early clinical trials with the NHS.

What Rock Labs does

Rock Labs is a UK-based, privately held health technology company developing point-of-care cortisol monitoring technology for endocrine health management, with particular focus on adrenal insufficiency. The company serves two primary customer personas: patients and carers managing hormonal conditions who lack practical day-to-day monitoring tools, and clinicians supporting those patients who need longitudinal visibility beyond clinic visits. Its business is presently structured as pre-revenue clinical development rather than commercial sales, with the company explicitly stating its technology is in clinical trials and not available outside regulated pathways.

The company's product portfolio centers on two offerings. The core Cortisol Monitoring Technology is a point-of-care sensing programme combining proprietary sensing hardware, algorithms, secure data handling, and analysis software designed to support both patients and clinicians within regulatory pathways. A complementary Symptom-Tracker mobile application has been developed to help parents manage childhood adrenal insufficiency at home via patient-reported data. Technical differentiation is grounded in domain specialisation in endocrine health rather than general-purpose biosensing, with hardware, algorithms, and user experience refined in collaboration with NHS clinical teams and patients.

Rock Labs operates on a planned subscription/recurring revenue model to be activated post-approval, with anticipated distribution routed through health systems, payers, and pharmaceutical partners rather than direct consumer sales. Its commercial pipeline is anchored by three core strategic partners: the NHS, Royal Manchester Children's Hospital (clinical co-development), and The Pituitary Foundation (patient advocacy and lived-experience input). Company research has been disseminated through poster abstracts at the British Society for Paediatric Endocrinology and Diabetes (BSPED) annual meetings in 2024 and 2025, published in Endocrine Abstracts. The company is small (1-10 employees), bootstrapped or grant-funded to date, and led by Founder & CEO Ben Marinic with an advisory bench including Prof. Indi Banerjee (paediatric endocrinology) and Bev Hurley CBE (commercialisation).

Rock Labs firmographics

Firmographics
Name
Rock Labs
Legal name
Rock Labs Ltd
Website
https://rocklabs.co
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Short description
Rock Labs is a UK-based pre-revenue health technology company developing point-of-care cortisol monitoring sensing hardware and a symptom-tracking mobile app for patients with hormonal conditions, currently in early clinical trials with the NHS.
Ownership category
akta.pro rank

Rock Labs industry classification

Industry
Product category
Digital Health — Endocrine Health Monitoring
NAICS
Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), In Vitro & In Vivo Diagnostic Substances (2835), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLACAOAL
Decentralized/Hybrid Trial Enablement (DCT) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

Keywords

  • Cortisol monitoring
  • Endocrine health platform
  • Digital health sensing
  • Clinical decision support
  • Symptom tracking app

Where Rock Labs is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Rock Labs business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

  1. Pre-Revenue / Development Stage: Rock Labs is in clinical trials stage with its technology. The company works with health systems, payers, and pharmaceutical partners who help make tools available to patients when evidence and approvals support that. No commercial revenue has been generated as the technology is not yet a finished product.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Rock Labs product offering

Product offering

Core offering

Rock Labs develops an integrated point-of-care cortisol monitoring platform that combines proprietary sensing hardware, secure data handling, and software with AI/ML analytics to support patients and clinicians in managing cortisol-related hormonal conditions such as adrenal insufficiency. A complementary symptom-tracker mobile application supports home management, particularly for paediatric adrenal insufficiency. The technology is currently in early clinical trials in collaboration with the NHS and is not yet a commercially available finished product.

Product overview

Rock Labs is developing an integrated endocrine health platform focused on cortisol monitoring. The core offering consists of a point-of-care cortisol monitoring technology (currently in early clinical trials) that combines sensing hardware, secure data handling, and analysis software to support both patients and clinicians. A complementary symptom-tracker mobile application has been developed for home management of childhood adrenal insufficiency. The platform is designed to provide precise, longitudinal insight into cortisol-related health, with an emphasis on real-life usability rather than clinical settings alone.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cortisol Monitoring Technology An integrated point-of-care cortisol monitoring platform combining proprietary sensing hardware, secure data handling, and analysis software (including AI/ML) to provide longitudinal insight into cortisol-related health. Designed to support both patients living with hormonal conditions such as adrenal insufficiency and the clinicians who care for them. Currently in early clinical trials and not yet a finished commercial product.
  • Symptom-Tracker App A mobile application designed to help parents manage childhood adrenal insufficiency at home by enabling symptom tracking and supporting optimisation of treatment plans through patient-reported data. Developed in collaboration with NHS clinical teams and The Pituitary Foundation with lived-experience input from families.

Companies that use Rock Labs

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Rock Labs technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Rock Labs partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • NHScoreStrategic or Co-development PartnerNHS partnership for developing and validating endocrine health monitoring technologies. The collaboration supports making Rock Labs tools available to patients through health system pathways when evidence and approvals support that.
  • Royal Manchester Children's HospitalcoreStrategic or Co-development PartnerClinical collaboration with NHS clinical teams at Royal Manchester Children's Hospital for developing monitoring tools, particularly for adrenal insufficiency in pediatric patients. Team members have co-authored research with hospital staff.
  • The Pituitary FoundationcoreStrategic or Co-development PartnerPatient advocacy partnership with The Pituitary Foundation including lived-experience input into product development. Collaboration ensures tools are grounded in real patient and carer needs.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Rock Labs competitors and assessment

Company assessment

Broad incumbents

  • Dexcom: Leading continuous glucose monitoring company with established hardware, software, and clinical evidence infrastructure. Comparable business model (continuous biochemical sensing + app + clinical decision support) and a benchmark for what successful endocrine monitoring scale looks like.
  • Roche Diagnostics: Global diagnostics incumbent with established cortisol immunoassays and immunoassay platforms used in clinical labs. Comparable on the diagnostic substance/testing side; an incumbent Rock Labs must differentiate against on performance, accessibility, and patient experience.
  • Abbott (Diagnostics & Diabetes Care): Global diagnostics and medical device incumbent operating FreeStyle Libre CGM and a broad immunoassay portfolio that includes cortisol testing. Comparable on the cortisol diagnostic side and a likely competitive threat via scale, distribution, and clinical evidence resources.

Emerging players

  • Function Health: Comprehensive at-home biomarker and lab testing platform with a software layer for longitudinal tracking and clinical decision support. Comparable in combining diagnostic testing, consumer health focus, and longitudinal data platform, though broader than endocrine.
  • Huma: UK-headquartered digital health platform combining remote patient monitoring, decentralized clinical trials, and AI-driven decision support. Comparable in combining RPM software, clinical partnerships, and pharma/health-system GTM, but operating at much broader scale.
  • Biofourmis: AI-driven remote patient monitoring and decentralized clinical trial platform focused on chronic conditions. Comparable technology stack (sensors + software + AI for clinical decision support) and enterprise health-system go-to-market motion.
  • Spren: Digital health startup using sensors and software to track hormonal biomarkers (cortisol) via wearable signals. Closely comparable in combining novel sensing with a software/AI layer to surface cortisol insight for consumers and clinicians.

Direct peers

  • Thriva: UK-based at-home blood testing service delivering biomarker results to consumers with clinician follow-up. Comparable to Rock Labs as a UK digital health company translating lab diagnostics into consumer/patient-friendly monitoring, though Thriva is further along commercially and not focused on cortisol.
  • Medichecks: UK-based at-home blood testing platform offering a wide range of hormone and endocrine panels, including cortisol. Similar at-home diagnostic model and UK regulatory pathway, with overlap in target endocrinology use cases.
  • Levels Health: US consumer metabolic monitoring company using continuous glucose sensing plus software to give users real-time insight and clinical decision support. Closely comparable model: sensing hardware + software + AI for day-to-day metabolic/hormonal condition management.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Rock Labs social profiles

Digital presence

Rock Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rock Labs leadership team

Management profile

Number of profiles

Profiles4 records

Rock Labs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rock Labs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rock Labs

What does Rock Labs do?

Rock Labs develops an integrated point-of-care cortisol monitoring platform that combines proprietary sensing hardware, secure data handling, and software with AI/ML analytics to support patients and clinicians in managing cortisol-related hormonal conditions such as adrenal insufficiency. A complementary symptom-tracker mobile application supports home management, particularly for paediatric adrenal insufficiency. The technology is currently in early clinical trials in collaboration with the NHS and is not yet a commercially available finished product.

Is Rock Labs a public or private company?

Rock Labs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Rock Labs founded?

Rock Labs was founded in 2014. It employs 1 to 10 people.

Where is Rock Labs based?

Rock Labs is headquartered in London, United Kingdom, in the Europe region.

How does Rock Labs make money?

One revenue line is on record: pre-Revenue / Development Stage.

Who are Rock Labs's main competitors?

Broad incumbents on record are Dexcom, Roche Diagnostics and Abbott (Diagnostics & Diabetes Care). Emerging players are Function Health, Huma, Biofourmis and Spren. Direct peers are Thriva, Medichecks and Levels Health.

Does Rock Labs have an API?

No public API is recorded for Rock Labs.

What industry is Rock Labs in?

Rock Labs's product category is Digital Health — Endocrine Health Monitoring. Its primary akta.pro industry code is HLACAPAK, Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices), with a secondary code of HLACAFAL, Connected Therapeutics & Smart Drug Delivery Monitoring. Its NAICS code is 62151 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals